Skip to main content

Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ.

Publication ,  Journal Article
Hou, R; Grimm, LJ; Marks, JR; King, LM; Lynch, T; Rogers, K; Lyburn, ID; Stone, N; Wallis, M; Mann, RM; Lips, EH; Alaeikhanehshir, S; Lo, JY ...
Published in: Radiology
November 2025

Background Patients diagnosed with ductal carcinoma in situ (DCIS) may also have undetected invasive breast cancer. Radiomic features of calcifications at mammography can predict occult invasive disease among women diagnosed with DCIS at core-needle biopsy, which could affect treatment recommendations. However, the generalizability of these radiomic models must be tested before they are adopted in clinical practice. Purpose To evaluate the generalizability of radiomic models based on mammography features to predict occult invasive cancer among women diagnosed with DCIS at core-needle biopsy from three national datasets. Materials and Methods In this retrospective, cross-national study, digital mammograms from women diagnosed with DCIS at breast core-needle biopsy were collected in the United States, United Kingdom, and the Netherlands between January 1, 2000, and December 31, 2021. Only asymptomatic women who had calcifications but did not have associated masses, architectural distortions, or asymmetries were included. Radiomic models were developed using cross-validated logistic regression on each national dataset, then round-robin tested on the other datasets. Differences across the three datasets in terms of the upstaging rate, age, lesion size, and estrogen and progesterone receptor levels were assessed using Kruskal-Wallis or χ2 test. Results The study included 1498 women (age range, 31-89 years; mean age, 59 years ± 9 [SD]), as follows: 696 women from the United States, 618 women from the United Kingdom, and 184 women from the Netherlands, with upstaging rates of 16.1%, 16.7%, and 14.1%, respectively. Internal cross-validation areas under the receiver operating characteristic curve (AUCs) were 0.675 (95% CI: 0.671, 0.679), 0.603 (95% CI: 0.567, 0.722), and 0.701 (95% CI: 0.697, 0.706) for the U.S., UK, and Netherlands datasets, respectively. The model that was trained on the U.S. dataset yielded cross-national validation AUCs of 0.604 (95% CI: 0.560, 0.648) and 0.682 (95% CI: 0.607, 0.757) for the UK and Netherlands datasets. Conclusion Radiomic machine learning models were shown to have the potential to predict occult invasive cancer in women with DCIS across diverse settings. © RSNA, 2025 Supplemental material is available for this article.

Duke Scholars

Published In

Radiology

DOI

EISSN

1527-1315

Publication Date

November 2025

Volume

317

Issue

2

Start / End Page

e243739

Location

United States

Related Subject Headings

  • United States
  • United Kingdom
  • Retrospective Studies
  • Radiomics
  • Nuclear Medicine & Medical Imaging
  • Netherlands
  • Neoplasm Invasiveness
  • Middle Aged
  • Mammography
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hou, R., Grimm, L. J., Marks, J. R., King, L. M., Lynch, T., Rogers, K., … Grand Challenge PRECISION consortium. (2025). Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ. Radiology, 317(2), e243739. https://doi.org/10.1148/radiol.243739
Hou, Rui, Lars J. Grimm, Jeffrey R. Marks, Lorraine M. King, Thomas Lynch, Keith Rogers, Iain D. Lyburn, et al. “Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ.Radiology 317, no. 2 (November 2025): e243739. https://doi.org/10.1148/radiol.243739.
Hou R, Grimm LJ, Marks JR, King LM, Lynch T, Rogers K, et al. Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ. Radiology. 2025 Nov;317(2):e243739.
Hou, Rui, et al. “Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ.Radiology, vol. 317, no. 2, Nov. 2025, p. e243739. Pubmed, doi:10.1148/radiol.243739.
Hou R, Grimm LJ, Marks JR, King LM, Lynch T, Rogers K, Lyburn ID, Stone N, Wallis M, Mann RM, Lips EH, Alaeikhanehshir S, van Leeuwen MM, Teuwen J, Wesseling J, Lo JY, Hwang ES, Grand Challenge PRECISION Consortium, Grand Challenge PRECISION consortium. Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ. Radiology. 2025 Nov;317(2):e243739.

Published In

Radiology

DOI

EISSN

1527-1315

Publication Date

November 2025

Volume

317

Issue

2

Start / End Page

e243739

Location

United States

Related Subject Headings

  • United States
  • United Kingdom
  • Retrospective Studies
  • Radiomics
  • Nuclear Medicine & Medical Imaging
  • Netherlands
  • Neoplasm Invasiveness
  • Middle Aged
  • Mammography
  • Humans